13F-HR filed by Lunate Capital Ltd
Lunate Capital Ltd filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-01-23, with 6 holding rows worth $264,258,501.
- Accession
- 0001011438-26-000036
- Filer
- CIK 2056786
- Filed
- 2026-01-23
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 6 entries on the cover page, a total value of $264,258,501 stated on the cover page (in dollars after the unit check, H1), rows summing to $264,258,501 with VALUE read as dollars as filed, 13F file number 028-25509. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerLunate Holding RSC Ltd028-25201
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,196,200 | $174,927,330 | dollars as filed | |
| SAILPOINT INC COM | 78781J109 | Stock | 3,000,000 | $60,690,000 | dollars as filed | |
| LINEAGE INC COM | 53566V106 | REIT | 600,000 | $21,000,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 2,124,143 | $3,802,216 | dollars as filed | |
| NAVAN INC CL A | 639193101 | Stock | 200,000 | $3,416,000 | dollars as filed | |
| REVOLUTION MEDICINES INC | 76155X118 | *W EXP 12/17/202 | 450,000 | $422,955 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001011438-26-000036 | this filing | 2026-01-23 | acceptance time not in the bulk data set |